CD30, Human (Brentuximab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-CD30, Human (Brentuximab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD30, Human (Brentuximab biosimilar)
CloneBrentuximab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeHuman IgG1
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human CD30 Recombinant Antibody (Brentuximab). Brentuximab vedotin (INN, trade name Adcetris) is an antibody-drug conjugate medication used to treat relapsed or refractory Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (ALCL), a type of T cell non-Hodgkin lymphoma. It selectively targets tumor cells expressing the CD30 antigen, a defining marker of Hodgkin lymphoma and ALCL.
Immunogenn/a
Other NamesAnti-CD30 Recombinant Antibody, Research Grade Brentuximab, Anti-Human CD30 Recombinant Antibody(Brentuximab), , Antibody Drug Analogues, Monoclonal Antibody, YR1614, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #n/a
Catalog #YR1614
Priceplease inquire
Order / More InfoCD30, Human (Brentuximab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.